Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 71

Sort by

Sort Order Select

Journal Articles

Rheological Comparison of Red Cells from Individuals with SCD Treated with Gene Therapy, Haploidentical Transplantation or Hydroxyurea

Britney Hernandez, Ashwin P. Patel, Erica N Evans, Jordan Zgodny, Stephen Gottschalk, Brandon M Triplett, Serena De Vita, Kirby Wallace, David C Shyr, Elizabeth O Stenger, Suhag Parikh, Akshay Sharma, Vivien Sheehan

Blood (2024) 144 (Supplement 1): 4956.

https://doi.org/10.1182/blood-2024-210578

Published: 2024

Journal Articles

Kidney Outcomes after Hematopoietic Cell Transplantation in Children and Young Adults with Sickle Cell Disease

Rima Zahr, Yu Bi, Subodh Selukar, Stephen Gottschalk, Brandon M Triplett, Alexis Kristine Leonard, Akshay Sharma

Blood (2024) 144 (Supplement 1): 5067.

https://doi.org/10.1182/blood-2024-209896

Published: 2024

Journal Articles

Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease

Alexis Kristine Leonard, Akshay Sharma, Yogindra Persaud, Parul Rai, Darla Pickett, Renee Massey, Neha Das Gupta, Subodh Selukar, Salem M. Akel, Leigh Poston, Yan Zheng, Ella Sorani, Irit Gliko Kabir, Mitchell J Weiss, Stephen Gottschalk, Julie Kanter, Matthew Hsieh, John Tisdale

Blood (2024) 144 (Supplement 1): 2100.1.

https://doi.org/10.1182/blood-2024-200330

Published: 2024

Journal Articles

CD123-CAR T Cells Manufactured in the Presence of Dasatinib Induce High Grade CRS and/or IEC-HS without Improving Efficacy in Pediatric Patients with Recurrent/Refractory Leukemia

Blood (2024) 144 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2024-208795

Published: 2024

Journal Articles

Health-Related Quality of Life Post-Hematopoietic Cell Transplantation in Sickle Cell Disease: Differences in Patient Self-Report and Caregiver Report

Jerlym Porter, Kathryn Russell, Kendra Parris, Sean Phipps, Alexis Kristine Leonard, Brandon M Triplett, Stephen Gottschalk, Akshay Sharma

Blood (2024) 144 (Supplement 1): 7676.

https://doi.org/10.1182/blood-2024-211217

Published: 2024

Journal Articles

Memory T-Cell Add Back and Prophylactic blinatumomab Post Tcrαβ Depleted Haploidentical Transplantation Results in Promising Outcomes in Pediatric Patients with High-Risk Acute Leukemia

Blood (2024) 144 (Supplement 1): 383.

https://doi.org/10.1182/blood-2024-208547

Published: 2024

Journal Articles

Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease

Akshay Sharma, Subodh Selukar, Yu Bi, Anthony Merlocco, Cara E. Morin, Chris Goode, Parul Rai, Jeffrey A. Towbin, Jane S. Hankins, Stephen Gottschalk, Brandon Triplett, Jason N. Johnson

Blood (2024) 144 (6): 672–675.

https://doi.org/10.1182/blood.2023023028

Published: 2024

Includes: Supplemental data

Journal Articles

Is immune escape in the rearview mirror?

Swati Naik, Stephen Gottschalk

Blood (2024) 143 (2): 97–98.

https://doi.org/10.1182/blood.2023022178

Published: 2024

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study

Shruthi Suryaprakash, Yu Bi, Subodh Selukar, Dinesh Keerthi, Amr Qudeimat, Aimee C. Talleur, Ewelina K. Mamcarz, Ashok Srinivasan, Madden Renee, Rebecca Epperly, Swati Naik, Stephen Gottschalk, Brandon M Triplett, Akshay Sharma

Blood (2023) 142 (Supplement 1): 7087.

https://doi.org/10.1182/blood-2023-179853

Published: 2023

Journal Articles

Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease

Shruthi Suryaprakash, Yilun Sun, Li Tang, Dinesh Keerthi, Amr Qudeimat, Aimee C. Talleur, Ewelina K. Mamcarz, Ashok Srinivasan, Madden Renee, Rebecca Epperly, Swati Naik, Stephen Gottschalk, Brandon M Triplett, Akshay Sharma

Blood (2023) 142 (Supplement 1): 7042.

https://doi.org/10.1182/blood-2023-182639

Published: 2023

Journal Articles

Engineering naturally occurring CD7 − T cells for the immunotherapy of hematological malignancies

Blood (2022) 140 (25): 2684–2696.

https://doi.org/10.1182/blood.2021015020

Published: 2022

Includes: Supplemental data

Journal Articles

Establishing Immunocompetent Leukemia Models to Investigate the Impact of CAR T Cells on the Immune Microenvironment and Bone Marrow Niche

Sarah E. Moore, Jaquelyn T. Zoine, Jeremy Chase Crawford, Deanna Langfitt, Juan M. Barajas, Sherif Abdelhamed, Ilaria Iacobucci, Dalia Haydar, Giedre Krenciute, Charles G. Mullighan, Jeffery M. Klco, Stephen Gottschalk, Paul G. Thomas, Mireya Paulina Velasquez

Blood (2022) 140 (Supplement 1): 7376–7377.

https://doi.org/10.1182/blood-2022-169800

Published: 2022

Journal Articles

LigandCD70.CAR As a Platform for Dual-Targeting CAR T Cells for Acute Myeloid Leukemia

Lauren Scherer, Candise Tat, Tim Sauer, Haruko Tashiro, Swati Naik, Mireya Paulina Velasquez, Stephen Gottschalk, Cliona M. Rooney, Malcolm K. Brenner, Bilal Omer

Blood (2022) 140 (Supplement 1): 7396–7397.

https://doi.org/10.1182/blood-2022-170503

Published: 2022

Journal Articles

Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial

Blood (2022) 140 (Supplement 1): 4584–4585.

https://doi.org/10.1182/blood-2022-170201

Published: 2022

Journal Articles

Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

Blood (2022) 140 (1): 16–24.

https://doi.org/10.1182/blood.2022015728

Published: 2022

Journal Articles

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Blood (2022) 139 (17): 2706–2711.

https://doi.org/10.1182/blood.2021014648

Published: 2022

Includes: Supplemental data

Journal Articles

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

Blood (2021) 138 (Supplement 1): 471.

https://doi.org/10.1182/blood-2021-149332

Published: 2021

Journal Articles

CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies

Swati Naik, Aimee C Talleur, Ying Li, Renee M. Madden, Ewelina Mamcarz, Amr Qudeimat, Akshay Sharma, Ashok Srinivasan, Ali Y Suliman, Rebecca Epperly, Esther A. Obeng, Mireya Paulina Velasquez, Diego Hijano, Gabriela Maron, Stephen Gottschalk, Brandon M Triplett

Blood (2021) 138 (Supplement 1): 172.

https://doi.org/10.1182/blood-2021-149655

Published: 2021

Journal Articles

CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia

Swati Naik, Renee M. Madden, Ewelina Mamcarz, Ashok Srinivasan, Akshay Sharma, Aimee C Talleur, Rebecca Epperly, Amr Qudeimat, Ali Y Suliman, Esther A. Obeng, Mireya Paulina Velasquez, Diego Hijano, Gabriela Maron, Ying Li, Stephen Gottschalk, Brandon M Triplett

Blood (2021) 138 (Supplement 1): 2897.

https://doi.org/10.1182/blood-2021-149671

Published: 2021

Journal Articles

CD19-CAR T Cells Develop Exhaustion Epigenetic Programs during a Clinical Response

Caitlin C. Zebley, Charmaine Brown, Tian Mi, Yiping Fan, Shanta Alli, Shannon Boi, Giovanni Galletti, Enrico Lugli, Deanna Langfitt, Jean-Yves Metais, Timothy Lockey, Michael M Meagher, Brandon M Triplett, Aimee C Talleur, Stephen Gottschalk, Benjamin Youngblood

Blood (2021) 138 (Supplement 1): 2782.

https://doi.org/10.1182/blood-2021-151177

Published: 2021

NARROW

Rheological Comparison of Red Cells from Individuals with SCD Treated with Gene Therapy, Haploidentical Transplantation or Hydroxyurea

Kidney Outcomes after Hematopoietic Cell Transplantation in Children and Young Adults with Sickle Cell Disease

Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease

CD123-CAR T Cells Manufactured in the Presence of Dasatinib Induce High Grade CRS and/or IEC-HS without Improving Efficacy in Pediatric Patients with Recurrent/Refractory Leukemia

Health-Related Quality of Life Post-Hematopoietic Cell Transplantation in Sickle Cell Disease: Differences in Patient Self-Report and Caregiver Report

Memory T-Cell Add Back and Prophylactic blinatumomab Post Tcrαβ Depleted Haploidentical Transplantation Results in Promising Outcomes in Pediatric Patients with High-Risk Acute Leukemia

Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease

Is immune escape in the rearview mirror?

Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study

Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease

Engineering naturally occurring CD7 − T cells for the immunotherapy of hematological malignancies

Establishing Immunocompetent Leukemia Models to Investigate the Impact of CAR T Cells on the Immune Microenvironment and Bone Marrow Niche

LigandCD70.CAR As a Platform for Dual-Targeting CAR T Cells for Acute Myeloid Leukemia

Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial

Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

Donor-derived multiple leukemia antigen–specific T-cell therapy to prevent relapse after transplant in patients with ALL

Donor-Derived Adoptive T-Cell Therapy Targeting Multiple Tumor Associated Antigens to Prevent Post-Transplant Relapse in Patients with ALL

CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies

CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia

CD19-CAR T Cells Develop Exhaustion Epigenetic Programs during a Clinical Response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only